Jubilant's Radiopharma biz gets USFDA approval for Technetium Mertiatide injection

Image
Capital Market
Last Updated : Feb 01 2023 | 8:50 AM IST

This approval is effective from 30 January 2023.

Jubilant Pharmova's wholly owned subsidiary Jubilant Draximage Inc announced that it received approval from the US drug regulator (USFDA) with regards to the company's new drug application (NDA) submitted pursuant to section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act (FDCA) for Kit for the Preparation of Technetium (Tc 99m) Mertiatide injection.

The Tc 99m Mertiatide injection is used in the diagnosis of congenital and acquired renal abnormalities, renal failure, urinary tract obstruction, and calculi in adults and pediatric patients aged 30 days and older.

The product enables providing renal function, split function, renal angiograms, and renogram curves for whole kidney and renal cortex.

Jubilant Pharmova (formerly Jubilant Life Sciences) is engaged in Radiopharma, Allergy Immunotherapy, CDMO of Sterile Injectable, Generics, Contract Research Development and Manufacturing (CRDMO) and Proprietary Novel Drugs businesses.

With a network of 46 radio-pharmacies in the US, Jubilant's Radiopharma business is engaged in manufacturing and supply of Radiopharmaceutical products and services.

On a consolidated basis, net profit of Jubilant Pharmova declined 96.16% to Rs 5.49 crore on 3% decline in net sales to Rs 1584.74 crore in Q2 September 2022 over Q2 September 2021.

Shares of Jubilant Pharmova jumped 4.50% to Rs 351.95 on Tuesday, 31 January 2023.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Great minds don’t just skim the surface, they uncover the full story.

Already subscribed? Log in

Subscribe to read the full story →

Smart Quarterly

₹900

3 Months

₹300/Months/month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Months/month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Unlimited access to all articles

  • 30+ premium stories daily, handpicked by our editor

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio

  • Wirecutter & The Athletic

Complimentary Access to Our e-Paper

  • Digital replica of our daily newspaper

  • Read, save, share any article

Curated Newsletters on Diverse Topics

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Smart Investment Tips

  • In-depth stock analysis & insights

  • The Smart Investor for wealth growth tips

Access to Extensive Historical Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading Experience

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Repository of articles and publications dating back to 1997

More From This Section

Gold price in Delhi today is ₹ 84,470, Click Here for other cities. Silver price in Delhi today is ₹ 84,470, Click Here for other cities.

First Published: Feb 01 2023 | 8:31 AM IST

Subscribe to read without limits
Subscribe Now
Next Story